-18%
Getz Pharma
Aireez Tablets 10mg 30s
10 Strips
Rated 4.5 out of 5 (6)
Rs. 225Rs. 275
In Stock
Reckitt
Optra Inhaler 20mcg 200 Doses
Rated 4.5 out of 5 (35)SKU HP-16086
A inhaler containing Ipratropium Bromide, indicated for Chronic Obstructive Pulmonary Disease.
Rs. 1,015
100ml Syrup
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Optra Inhaler 20mcg 200 Doses quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 1,015
What it is used for: Chronic Obstructive Pulmonary Disease.
Indications as listed by the manufacturer: Ipratropium bromide is indicated as: - Bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. - Adjunct to beta2-agonists in the management of acute severe asthma.
How it works: Ipratropium bromide is an anticholinergic (parasympatholytic) agent it appears to inhibits the vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++ which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. The bronchodilation following inhalation of ipratropium bromide is induced by local drug concentrations sufficient for anticholinergic efficacy at the bronchial smooth muscle and not by systemic concentrations.
Active ingredient: Ipratropium Bromide.
Reported side effects: Common: Headache, dizziness, cough, throat irritation, nausea, dryness of mouth and gastrointestinal motility disorder. Uncommon: Blurred vision, mydriasis, intraocular pressure increased, eye pain, halo vision, conjunctival hyperemia, corneal oedema, glaucoma, anaphylactic reaction, hypersensitivity, angioedema of tongue, lips & face, palpitations, supraventricular tachycardia, bronchospasm, paradoxical bronchospasm, laryngospasm, pharyngeal oedema, dry throat, diarrhea, constipation, vomiting, stomatitis, rash, pruritus and urinary retention. Rare: Accommodation disorder, atrial fibrillation, heart rate increased and urticaria.
Known drug interactions: Administration of ipratropium bromide with beta-adrenergics and xanthine preparations may intensify the bronchodilator effect. Co-Administration of ipratropium bromide with other anticholinergic drugs should be avoided, as this may lead to an increase in anticholinergic adverse effects.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Inhaler : Adults (including the elderly): Usually 1 or 2 inhalations three or four times daily, although some patients may need up to 4 inhalations at a time to obtain maximum benefit during early treatment. Patients may take additional inhalations as required, however, the total number of inhalations should not exceed 12 in 24 hours. Children: Between 6-12 years: Usually 1 or 2 inhalations, three times daily. Under 6 years: Usually 1 inhalation, three times daily. In order to ensure that the inhaler is used correctly, administration should be supervised by an adult. The recommended dose should not be exceeded. Nebulizer Soln : Adults : 0.2-2ml by nebulizer upto three times daily. <3yr, not recommended. Always consult doctor or pharmacist for dose adjustments.
Active ingredient: Ipratropium Bromide. Labelled strength: 20mcg.
- Ipratropium bromide is contraindicated in patients with: - Hypersensitivity to Ipratropium bromide or to any excipeint of the product. - Hypersensitivity to atropine or its derivatives.
- Ipratropium bromide is an anticholinergic and its use may increase intraocular pressure. This may result in precipitation or worsening of narrow-angle glaucoma. Therefore, it should be used with caution in patients with narrow-angle glaucoma. Patients should avoid spraying ipratropium bromide inhaler into the eye.
- Ipratropium bromide can produce paradoxical bronchospasm that can be life threatening. If this occurs, treatment with ipratropium bromide should be stopped and other treatments considered.
- Hypersensitivity reactions including urticaria, angioedema, rash, bronchospasm, anaphylaxis and oropharyngeal edema, may occur after the a dministration of ipratropium bromide. If such a reaction occurs, therapy with ipratropium bromide should be stopped at once and alternative treatment should be considered.
- Ipratropium bromide is a bronchodilator for the maintenance treatment of bronchospasm associated with COPD and is not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Optra Laboratories (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 535 verified ratings
- 5★50%
- 4★50%
- 3★0%
- 2★0%
- 1★0%
- Imran Q.Verified Purchase4 Aug 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Shahid HussainVerified Purchase21 Jul 2026Rated 5.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Komal J.Verified Purchase11 Jul 2026Rated 4.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Faisal SheikhVerified Purchase23 Jun 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Chronic Obstructive Pulmonary Disease.
Indications as listed by the manufacturer: Ipratropium bromide is indicated as: - Bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. - Adjunct to beta2-agonists in the management of acute severe asthma.
How it works: Ipratropium bromide is an anticholinergic (parasympatholytic) agent it appears to inhibits the vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++ which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. The bronchodilation following inhalation of ipratropium bromide is induced by local drug concentrations sufficient for anticholinergic efficacy at the bronchial smooth muscle and not by systemic concentrations.
Active ingredient: Ipratropium Bromide.
Reported side effects: Common: Headache, dizziness, cough, throat irritation, nausea, dryness of mouth and gastrointestinal motility disorder. Uncommon: Blurred vision, mydriasis, intraocular pressure increased, eye pain, halo vision, conjunctival hyperemia, corneal oedema, glaucoma, anaphylactic reaction, hypersensitivity, angioedema of tongue, lips & face, palpitations, supraventricular tachycardia, bronchospasm, paradoxical bronchospasm, laryngospasm, pharyngeal oedema, dry throat, diarrhea, constipation, vomiting, stomatitis, rash, pruritus and urinary retention. Rare: Accommodation disorder, atrial fibrillation, heart rate increased and urticaria.
Known drug interactions: Administration of ipratropium bromide with beta-adrenergics and xanthine preparations may intensify the bronchodilator effect. Co-Administration of ipratropium bromide with other anticholinergic drugs should be avoided, as this may lead to an increase in anticholinergic adverse effects.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Inhaler : Adults (including the elderly): Usually 1 or 2 inhalations three or four times daily, although some patients may need up to 4 inhalations at a time to obtain maximum benefit during early treatment. Patients may take additional inhalations as required, however, the total number of inhalations should not exceed 12 in 24 hours. Children: Between 6-12 years: Usually 1 or 2 inhalations, three times daily. Under 6 years: Usually 1 inhalation, three times daily. In order to ensure that the inhaler is used correctly, administration should be supervised by an adult. The recommended dose should not be exceeded. Nebulizer Soln : Adults : 0.2-2ml by nebulizer upto three times daily. <3yr, not recommended. Always consult doctor or pharmacist for dose adjustments.
Active ingredient: Ipratropium Bromide. Labelled strength: 20mcg.
- Ipratropium bromide is contraindicated in patients with: - Hypersensitivity to Ipratropium bromide or to any excipeint of the product. - Hypersensitivity to atropine or its derivatives.
- Ipratropium bromide is an anticholinergic and its use may increase intraocular pressure. This may result in precipitation or worsening of narrow-angle glaucoma. Therefore, it should be used with caution in patients with narrow-angle glaucoma. Patients should avoid spraying ipratropium bromide inhaler into the eye.
- Ipratropium bromide can produce paradoxical bronchospasm that can be life threatening. If this occurs, treatment with ipratropium bromide should be stopped and other treatments considered.
- Hypersensitivity reactions including urticaria, angioedema, rash, bronchospasm, anaphylaxis and oropharyngeal edema, may occur after the a dministration of ipratropium bromide. If such a reaction occurs, therapy with ipratropium bromide should be stopped at once and alternative treatment should be considered.
- Ipratropium bromide is a bronchodilator for the maintenance treatment of bronchospasm associated with COPD and is not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Optra Laboratories (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 535 verified ratings
- 5★50%
- 4★50%
- 3★0%
- 2★0%
- 1★0%
- Imran Q.Verified Purchase4 Aug 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Shahid HussainVerified Purchase21 Jul 2026Rated 5.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Komal J.Verified Purchase11 Jul 2026Rated 4.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Faisal SheikhVerified Purchase23 Jun 2026Rated 5.0 out of 5
Exactly what my doctor prescribed. The pharmacist called to confirm the strength before dispatch, which I appreciated.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
ReckittOptra Inhaler 20mcg 200 DosesRs. 1,015Rated 4.5 out of 5
Highnoon LabsGenthro 500mg Tablets 6sRs. 1,275Rated 4.5 out of 5
StandpharmAtenorm Tablets 50mg 14sRs. 975Rated 4.5 out of 5
Bundle total
Rs. 3,265Rs. 3,440
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
